SEE ALSO...
Items 11 to 20 of 39 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxepin hydrochloride | 1229-29-4 | sc-203930 | 1 g | $52.00 | ||
Doxepin hydrochloride functions as a muscarinic acetylcholine receptor M modulator, characterized by its ability to engage in specific hydrogen bonding interactions with receptor sites. The presence of a tertiary amine allows for versatile conformational changes, enhancing its binding dynamics. Its unique electronic structure facilitates selective receptor activation, influencing downstream signaling cascades. Furthermore, the compound's solubility properties affect its distribution in biological systems, impacting its interaction with various cellular environments. | ||||||
(−)Scopolamine methyl nitrate | 6106-46-3 | sc-264301 sc-264301A | 1 g 5 g | $181.00 $525.00 | ||
(-)Scopolamine methyl nitrate acts as a muscarinic acetylcholine receptor M antagonist, exhibiting unique steric hindrance due to its bulky structure. This steric effect influences its binding affinity and selectivity, allowing for distinct receptor interactions. The compound's lipophilicity enhances membrane permeability, facilitating rapid distribution across lipid bilayers. Additionally, its reactivity with nucleophiles can lead to diverse metabolic pathways, affecting its overall pharmacokinetic profile. | ||||||
Trospium Chloride | 10405-02-4 | sc-208473 | 25 mg | $260.00 | 2 | |
Trospium Chloride functions as a muscarinic acetylcholine receptor M antagonist, characterized by its quaternary ammonium structure, which imparts a positive charge. This charge enhances its solubility in aqueous environments while limiting its ability to cross lipid membranes. The compound exhibits unique binding dynamics, with a preference for specific receptor conformations, influencing downstream signaling pathways. Its kinetic profile is marked by rapid receptor dissociation, allowing for transient modulation of cholinergic activity. | ||||||
Ipratropium bromide | 22254-24-6 | sc-203606 | 100 mg | $85.00 | 3 | |
Ipratropium bromide acts as a muscarinic acetylcholine receptor M antagonist, distinguished by its unique bicyclic structure that facilitates selective receptor binding. This compound exhibits a strong affinity for the receptor's active site, leading to competitive inhibition of acetylcholine. Its hydrophilic nature enhances solubility in biological fluids, while its steric configuration influences receptor interaction kinetics, resulting in a prolonged duration of action and modulation of cholinergic signaling pathways. | ||||||
Tiotropium Bromide Monohydrate | 139404-48-1 | sc-364685 | 5 mg | $200.00 | 2 | |
Tiotropium Bromide Monohydrate functions as a selective antagonist of muscarinic acetylcholine receptors, characterized by its unique tricyclic framework that promotes specific interactions with receptor sites. This compound demonstrates a high binding affinity, effectively blocking acetylcholine's action. Its distinct hydrophobic regions contribute to its stability and interaction dynamics, while the monohydrate form enhances solubility, facilitating its behavior in various environments and influencing receptor modulation. | ||||||
rac 5-Hydroxymethyl Tolterodine | 200801-70-3 | sc-208267 | 1 mg | $268.00 | ||
Rac 5-Hydroxymethyl Tolterodine acts as a modulator of muscarinic acetylcholine receptors, exhibiting a unique structural configuration that allows for selective receptor engagement. Its hydroxymethyl group enhances hydrogen bonding capabilities, influencing receptor conformation and signaling pathways. The compound's kinetic profile reveals a rapid onset of action, while its lipophilic characteristics facilitate membrane permeability, impacting its distribution and interaction with target sites. | ||||||
Homatropine methyl bromide | 80-49-9 | sc-295160 sc-295160A | 5 g 25 g | $174.00 $533.00 | ||
Homatropine methyl bromide is a potent antagonist of muscarinic acetylcholine receptors, characterized by its quaternary ammonium structure that enhances ionic interactions with receptor sites. This compound exhibits a unique ability to stabilize receptor conformations, leading to distinct signaling modulation. Its high lipophilicity promotes effective membrane partitioning, while its rapid kinetics facilitate swift receptor occupancy, influencing downstream physiological responses. | ||||||
(R)-Fesoterodine Fumarate | 286930-03-8 | sc-208238 | 2.5 mg | $237.00 | ||
(R)-Fesoterodine Fumarate acts as a selective antagonist at muscarinic acetylcholine receptors, showcasing a unique stereochemical configuration that enhances its binding affinity. Its molecular structure allows for specific hydrogen bonding and hydrophobic interactions, which contribute to its receptor selectivity. The compound's dynamic conformational flexibility enables it to modulate receptor activity effectively, influencing intracellular signaling pathways with notable precision. | ||||||
rac 5-Hydroxymethyl Tolterodine-d14 | sc-219791 | 1 mg | $490.00 | |||
Rac 5-Hydroxymethyl Tolterodine-d14 exhibits intriguing interactions with muscarinic acetylcholine receptors, characterized by its deuterated structure that alters isotopic effects on reaction kinetics. This compound's unique spatial arrangement facilitates distinct electrostatic interactions, enhancing its affinity for receptor sites. Additionally, its ability to adopt multiple conformations allows for nuanced modulation of receptor dynamics, potentially influencing downstream signaling mechanisms in a targeted manner. | ||||||
Trospium Bromide-d8 | sc-356178 | 10 mg | $2700.00 | |||
Trospium Bromide-d8 is a deuterated derivative that showcases unique binding characteristics with muscarinic acetylcholine receptors. The presence of deuterium modifies the vibrational frequencies of the molecule, potentially impacting its interaction dynamics. Its rigid structure promotes specific steric interactions, which may enhance selectivity for receptor subtypes. Furthermore, the compound's isotopic labeling can provide insights into metabolic pathways and receptor conformational changes during binding events. | ||||||